CD19-Directed CAR T-Cells in a Patient With Refractory MOGAD: Clinical and Immunologic Follow-Up for 1 Year.
Jose Maria Cabrera-MaquedaMaria SepúlvedaRaquel Ruiz GarcíaGuillermo Muñoz-SánchezNuria Martínez-CibrianValentín Ortíz-MaldonadoDaniel Lorca-ArceMar GuaspSara LlufriuEugenia Martinez-HernandezThaís ArmangueElianet G FonsecaMaría Teresa Alba-IsasiJulio DelgadoJosep O DalmauManel JuanAlbert SaizYolanda BlancoPublished in: Neurology(R) neuroimmunology & neuroinflammation (2024)
This provides Class IV evidence. It is a single observational study without controls.